Innovative medical technologies

Competition Briefing Event
Support for SMEs to evaluate
innovative medical
technologies
•Tuesday 3 July 2018
•Morning session

Agenda
• 10:30 Welcome, Housekeeping and Introduction – KTN
• 10:40 Background to call – Office for Life Sciences/Innovate UK
• 10:50 Competition Scope - Innovate UK Innovation Lead
• 11:20 Competition process – Innovate UK Competitions Team
• 11:50 Feedback from Round 1 and lessons learned – Innovate UK
• 12:15 Q&A
• 12:30-13:30 Lunch and Networking
•Morning

Housekeeping
• Emergency procedures
• Facilities
• Devices to silent
• Webinar
• - recording and slides will be published
• - please use microphones

Connecting people
to drive innovation
— Find expertise
— Find markets
— Find finance

The Future. Faster
As a network partner of Innovate UK,
KTN combines expertise in all sectors
with the ability to cross boundaries
Connecting with KTN can lead
to potential collaborations,
horizon-expanding events and
innovation insights relevant to
your needs

Growth through innovation
Helping you make
a success of your ideas
delivers growth for
the UK economy

How it works
— Attend events
— Receive expert advice
& insights
— Get help with
crossing sectors
— Introductions to
new collaborations

Business support offered by KTN
— Access to funding and finance
— Horizon 2020 guidance
— Embedding design and
sustainability in innovation

Activities and projects
From roadmaps to steering groups
from influencing government policy
to special interest groups,
our activities and projects
evolve constantly
to reflect industry needs

twitter:
web:
email:
Get in touch!
•Subscribe to our free newsletters -
•www.ktn-uk.org
•matt.chapman@ktn-uk.org
•@KTNUK-Health @mattchapmanktn
https://www.ktn-uk.co.uk/register

SME support to evaluate
innovative medical
technologies: round 2
03/07/2018

Overview
- Introduction to the Accelerated Access Review
- The competition
- Priority areas
- Eligible products
- Options for support
- State aid rules – an introduction to Article 28
- Key dates
- Round one and key messages

The Accelerated Access Review
- Independent report to Government
- Outlined a process for identifying and pulling
transformative innovations into the NHS
quickly
- Noted the need for the generation of patient
data that define the benefits of innovation
- Encouraged the NHS to work more
collaboratively with innovators to provide
the type of data health care systems need to
make decisions
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/565072/AAR_final.pdf

Accelerated Access Review
- Published November 2017
- Sets out a raft of methods to implement the
recommendations in the AAR that will
maximise the appropriate use of innovative
products
- Includes new the creation of an Accelerated
Access Collaborative to align national bodies
around accelerating innovation
- £6m scheme to support SMEs in obtaining an
effective evidence base for their medtech
products
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/664685/AAR_Response.pdf

Industrial Strategy: Life Sciences Sector Deal
Implementation of the AAR by:
- streamlining pathways and supporting small and
medium-sized businesses
- creation of the Accelerated Access Collaborative
- a streamlined pathway for breakthrough
products to market and then to patients
- £86m of government funding focused on
supporting innovators and the NHS locally
- a digital health catalyst
- improved commercial capacity and capability for
NHS England
https://www.gov.uk/government/publications/life-sciences-sector-deal

SME support to evaluate innovative medical technologies
- Second round of the competition in 2018
- Provides support for small and medium-sized enterprises (SMEs)
- It allows companies to collect and analyse clinical performance and cost
effectiveness data in an NHS setting
- Support for SMEs to develop an evidence base for their products to
facilitate the adoption of the innovations to delivery savings or improve
patient care
- Up to £1.5m funding is available - funded by the Office for Life Sciences
- Additional rounds of the competition are planned

All applications must be business-led
Support options:
1: Study planning and preparation
- Total project costs up to £50,000
2: Collection of clinical performance and cost-effectiveness data study
- Total project costs up to £250k
Projects must start by 1 January 2019 and be completed by the end of
December 2019.
Project size

Eligible products:
- includes medical devices, diagnostics and regulated digital
healthcare products
- must be CE marked
- cannot have been marketed in the UK for more than 5 years
- have a potentially significant impact, including increasing patient
access to innovative technologies where appropriate
Competition Scope

Priority areas
Priority will be given to products that address the priorities outlined in the
Next steps on the NHS 5 year forward view
- reduce cancellations or unnecessary appointments in primary and
secondary care
- reduce the burden on A&E services, for example by diverting footfall
- improve patient safety and avoid patient harm
- speed up diagnosis, such as improving the scope of lower cost diagnostic
imaging
- enable earlier diagnosis of cancer
- support the management of long term conditions
https://www.england.nhs.uk/wp-content/uploads/2017/03/NEXT-STEPS-ON-THE-NHS-FIVE-YEAR-FORWARD-VIEW.pdf

Proposals should include
- how your product is likely to have a significant impact
- evidence of the product’s clinical performance and cost effectiveness
- evidence that you are working with appropriate stakeholders including
NICE, NHS England, NIHR and AHSNs
- details of the development or implementation of plans for data
collection within the NHS
- outline how studies will generate data on the costs and benefits of a
product, allowing evaluation by NICE

Projects must
- focus on understanding evidence gaps and testing product performance
to explain the operational impact of your product on the NHS
- produce evidence of the impact of your technology
- expand the evidence base by adding data that can contribute to the
health technology appraisal process, for instance by comparing the use
of the new product with the current standard of care
- support identification of potential breakthrough technologies
- support the establishment of improved methods and systems, and
demonstrate how the product combined with health care system
adaptation delivers better outcomes at lower cost

Compliance with State Aid Rules
- This competition is being run under Article 28: Innovation Aid for SMEs
as described in the State Aid Manual (see page 41).
- It is important that you review the rules under innovation aid for SMEs
before you apply.
- Support up to 50% of eligible costs is available in this competition
- Grant support DOES NOT vary between eligible costs
- Ineligible costs include:
- Costs of instruments, equipment and materials
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/607691/bis-15-148-state-aid-manual-update.pdf

Article 28
Two categories are particularly relevant
in this competition:
- Secondment of highly qualified
personnel
- Costs of innovation advisory and
support services
If in doubt check with the State Aid
Manual and/or ask for advice
THIS
NOT THIS

- Opens 2 July 2018
- Closes noon 22 August 2018
- Applicants informed 2 November 2018
Full project brief and scope
- https://apply-for-innovation-funding.service.gov.uk/competition/190/overview
Further support is available:
- via our competition helpline on 0300 321 4357
- or email support@innovateuk.gov.uk
Additional competitions will follow
Competition dates and support

SME support to evaluate innovative
medical technologies: round 2
Applicant Briefing
3rd July 2018
03/07/2018

Laura Thomas – Portfolio Manager
Julie Brown – Portfolio Manager
Welcome and Introductions

Eligibility Criteria
Application process – the Innovation Funding Service
• Project details
• Application questions
Application Finances
• Project costs
• Academic partners
Submitting your application
Assessment
Project set-up for successful applicants
Q&A
Agenda

Option 1 - Study planning and
preparation
Option 2 - Collection of clinical
performance and cost-effectiveness data
study
Project
Eligibility
 Lead must be a UK based SME
 have a medical or diagnostic device, or a regulated digital health product with a CE
marking, that has been marketed for less than 5 years
 carry out your project within the NHS
 have a product that is aligned with the specific priority healthcare areas defined in
the Next steps on the NHS 5 year forward view
Project cost Up to £50k Up to £250k
Project length Projects must start by 1st January 2019 and finish by the 31st December 2019
Eligibility criteria

Making more than one application and
resubmissions
• SMEs can only submit one application to this round of the competition.
• If an application is unsuccessful, you can use the feedback received to reapply for the same project
into either another round of this competition or another competition. A project proposal can only be
submitted twice

Other Innovate UK projects
• If you have an outstanding final claim and Independent Accountant Report (IAR) on any
live Innovate UK project, you will not be eligible to apply for grant funding in this
competition, as a lead or a partner organisation.
• If you applied to a previous competition as the lead or sole company and were awarded
funding by Innovate UK, but did not make a substantial effort to exploit that award, we will
award no more funding to you.

Timeline Dates
Competition Opens 2nd July 2018
Briefing Event 3rd July 2018
Submission Deadline NOON 22nd August 2018
Applicants informed 2nd November 2018
Key Dates

How to apply using the Innovation Funding Service (IFS)

Innovation Funding Service users

Search for a funding competition and review criteria

37
Applicant: create an account

Spell check using your web browser
online guidance
assign the
question to a
collaborator
Formatting for
your content
Word count
Answering a question

40
The application form
Split into 3 Sections:
- Project Details
- Application Questions
- Your Finances

Application process
Project details

Project Details (Section 1)
• Application Details
- Title, Timescales, Research Category, Innovation Area & Resubmission (y/n)
• Project Summary
- Short summary and objectives of the project including what is innovative about it
• Public Description
- Description of your project which will be published if you are successful
• Scope
- How does your project align with the scope of this competition?
- If your project is not in scope, it will be ineligible for funding and not sent for assessment

Application form
Question 1 Need or challenge
Question 2 Approach and innovation
Question 3 Team and resources
Question 4 Market awareness
Question 5 Outcomes and route to market
Question 6 Wider impacts
Question 7 Project management
Question 8 Risks
Question 9 Additionality
Question 10 Costs and value for money
Appendix Q3
Appendix Q7
Appendix Q8
Appendix Q2
Application Questions (Section 2)
Detailed Guidance
Available on IFS

45
What is the business need, technological challenge or market opportunity
driving your innovation?
Question 1: Need or challenge
• Show evidence of the potential for your product to have a significant impact on patients, or the efficiency of care delivery by the NHS
• When the product was first marketed in the UK
If you are applying for option 1 funding:
 Explain/ justify why the study planning and preparation funding is necessary for you to keep developing your product
 give details of any gap analysis you have carried out into the clinical performance and cost-effectiveness of your product
 provide any specific advice you have received on evidence gaps, justifying any further work needed to define these gaps
 summarise the evidence requirement you are trying to fill
 show that you have performed an initial product evidence gap analysis using the NICE META tool, a comparable approach
or other product specific advice
 explain how your proposed study will fill the identified gaps
 tell us what evidence your study will gather and analyse

46
What approach will you take?
Question 2: Approach and innovation
What approach will you take?
• tell us how you will use the funding to develop and execute plans for data collection
• describe how you plan to contact and work with relevant stakeholders, including NICE, NHS
England, NIHR and AHSNs
• describe what work needs to be carried out during the study, and why
• describe how the study data will be collected and analysed
- describe how you plan to contact and work with NICE, NHS England, NIHR, AHSNs and other
stakeholders about the development of these plans
You may upload an appendix PDF document (max 1MB, 2 A4 pages) of
graphics/diagrams to demonstrate the innovation in your technology/product/service

47
Who is in the project team and what are their roles?
Question 3: Team and resources
• Describe the roles, skills and relevant experience of all members of the project
team
• State the resources, equipment and facilities required for the project and how
you will access them
• Provide details of any key external parties, including sub-contractors
• (if collaborative) describe the current relationships between the project partners
and how these will change as a result of the project
• Are there any gaps in the team that will need to be filled?
You may upload an appendix PDF document (max 1MB, 4 A4 pages) to describe
the skills and experience of the main people who will be working on the project

48
What does the market you are targeting look like?
Question 4: Market awareness
What is the market(s) (domestic and/or international) that you will be targeting in the
project and any other potential markets?
You should consider:
• the size of the addressable market(s) for the project outcome(s)
• the structure and dynamics of the market, and predicted growth rates within clear
timeframes
• the main supply/value chains and business models in operation
• the current UK position in addressing this market
For highly innovative projects, where the market may be unexplored, explain:
• what the route to market could or might be
• what its size might be
• how the project will seek to explore the market potential
For other markets, briefly describe the size and key features of those

49
How do you propose to grow your business and increase your productivity
into the long term as a result of the project?
Question 5: Outcomes and route to market
Describe or explain:
• how you will use the project’s clinical data
• how you plan to develop the product further after your project is complete
• whether the data generated will contribute to a NICE medtech or diagnostics
guidance document, refinement of the product, or knowledge about the
impacts to the care pathway
• your current position in the markets and supply or value chains outlined, and
whether you will be extending or establishing your market position
• your target customers and/or end users, and the value to them, for example,
why would they use or buy it?

50
What impact might this project have outside the project team?
Question 6: Wider impacts
• Summarise the anticipated benefit of your product for one of the clinical or
operational areas listed in the competition scope.
• What are the economic benefits from the project, to those outside the project?
• Highlight the expected social and/or environmental impacts, either positive or
negative
• Explain any expected regional impacts of the project

51
How will you manage the project effectively?
Question 7: Project management
• Outline the main work packages of the project, indicating for each:
• The relevant research category
• The lead partner assigned
• The total cost of each package
• Describe your approach to project management and the management reporting
lines
• Outline your project plan in sufficient detail to identify any links or dependencies
between work packages or milestones
You may upload a project plan/Gantt chart in PDF format (max 1MB, 2 A4 pages) as
an appendix

52
What are the main risks for this project?
Question 8: Risks
• Identify the key risks and uncertainties of the project, including the technical,
commercial, managerial and environmental risks
• Explain how these risks will be mitigated
• List any project inputs on the critical path to completion (such as resources,
expertise, data sets)
• Are the outputs likely to be subject to regulatory requirements, certification,
ethical issues, etc.? If so how will you manage these?
You may upload a risk register in PDF format (max 1MB, 2 A4 pages) as an
appendix

53
Describe the impact that an injection of public funding would have on
this project.
Question 9: Additionality
• Tell us if this project could go ahead without public funding. If so, what
difference would the public funding make (such as faster to market, more
partners, reduced risk)?
• Describe the likely impact of the project on the businesses of the partners
involved
• Why are you unable to wholly fund the project from your own resources or
other forms of private-sector funding?
• Explain how this project would change the nature of the partners’ R&D activity
(and related spend)

54
How much will the project cost and how does it represent value for money
for the team and the taxpayer?
Question 10: Costs and value for money
• Justify the total project cost and the grant being requested, in line with the project
goals
• How will the partners finance their contributions to the project?
• Explain how this project represents value for money for you and the taxpayer.
• How will you finance your 50% contribution to the project?
• How you will cover any costs, such as material costs, that are not covered under
article 28 as listed on page 42 of the state aid manual?
• Describe any sub-contractor costs and why they are critical to the project

Businesses
No costs should be incurred
here so they will not need to
be completed on IFS

Eligible Costs
• Costs of obtaining, validating and defending patents and other intangible assets;
• Secondment of highly qualified personnel* from a research organisation or large
enterprise, working on research, development and innovation activities in a newly created
function within the beneficiary, not replacing existing personnel;
• Costs of innovation advisory and support services including consultancy, and training in the
areas of knowledge transfer, acquisition, protection and exploitation of intangible assets,
use of standards and regulations embedding them and the quality labelling, testing and
certification for the purpose of developing more effective products, processes or services.
*degree educated staff with ata least 5 years relevant professional experience, which may
include doctoral training

Labour costs
Ineligible:
•Dividends
•Bonuses
•Non productive time
Eligible:
•Staff working directly
on project.
•Paid by PAYE
•NI, pension, non-
discretionary costs.

Overheads
Innovate UK’s definition:
Additional costs and operational expenses incurred
directly as a result of the project. These could
include additional costs for administrative staff,
general IT, rent and utilities
Indirect (administration) overheads
• please ensure they are additional and
directly attributable to the delivery of
the project
Direct overheads
• E.g. office utilities, IT infrastructure,
laptop provision not covered by capital
usage
• must be directly attributable to the
project
• Provide detailed breakdown together
with methodology/basis of
apportionment

Sub-contract costs
Eligible:
•Justified and quantified

Travel and subsistence costs
Eligible:
Directly linked to the
project

Other costs
Eligible:
•Costs that could not be added under previous headings.
•Do not double count

Finances – your organisation

What we ask you:
• Organisation size
• Date of last financial year
• Financial overview
• Annual turnover
• Annual profits
• Annual export
• R&D spend
• No. full time employees

Funding
Funding rules
You could get funding of up to 50% of your eligible project costs - this will
need to be manually adjusted in IFS

Funding
• Each organisation
must accept the grant
terms and conditions
• The lead applicant
will not be able to
submit the
application without
all organisations
accepting the grant Ts
and Cs.

Finances overview
Please ensure your
total costs are within
the funding rules for
the competition

Non-grant claiming partners
• Lead must invite partner to join the application
• Partner must select “not requesting funding” option in finances section of
IFS
• Partner must complete “Your project costs” section to provide value of
their contribution
• Partner will not be named in the Grant Offer Letter if your project is
successful

Project cost summary
All organisations can see a summary of project costs

Checking your finances are complete
IFS checks
• all organisations have marked
their finances as complete

Review application before submission
IFS will check your application is
complete
All questions must be “marked as
complete”
Leave plenty of time to validate your
submission
Deadlines are absolute

Submit your application early!

Application Assessment
All applications are assessed by independent assessors drawn from industry
and academia
- What do they look for?
• Clear and concise answers
• The right amount of information
• not too much detail
• no assumptions
• Quantification and justification
• A proposal that presents a viable opportunity for growth, a level of innovation that necessitates
public sector investment and has the right team and approach to be successful
Keep your assessors engaged
and interested in your proposal.
You want them to be fascinated
and excited by your idea!

Project setup for successful applicants

IFS for successful applicants
Project Set up:
• 7 steps to complete
• Applicable to all grant claiming
partners
• Must be completed within 30 days
• Projects must start within 90 days or
funding may be withdrawn
• Project change requests cannot be
submitted before the project starts

Grant claims and payments
• All grants are claimable quarterly in arrears
• Claims can only be made for costs incurred and paid between the project start and end
dates
• Claims may be subject to an independent audit (including all academic partners)
according to grant size
• Claims are only paid once quarterly reporting and necessary audits are complete
• Projects over 6 months are monitored on a quarterly basis including a visit from the
appointed Monitoring Officer. Anything outside of this will be discussed on a case by case
basis.
• The monitoring will be carried out against a detailed project plan and financial forecast

Q&A – Application process and finances

Contact us:
Customer Support Services: 0300 321 4357 (Mon-Fri, 9am-5:30pm)
support@innovateuk.gov.uk
Knowledge Transfer Network:
https://www.ktn-uk.org
Innovate UK:
https://www.gov.uk/government/organisations/innovate-uk

Learning from Round 1
03/07/2018
SME support to
evaluate innovative
medical technologies:
round 2

Overview
• Round one competition outcome
• Specific lessons learned
• General aspects of assessment process
• Innovate UK expectations

Competition summary
Round one
• Opened 29 January 2018
• £1m funding available
• 25 applications
• 12 ineligible
• 13 assessed and 8 awarded funding
• Approximately £0.5m funding awarded
• Diverse range of funded projects involving medical devices,
diagnostic tests and digital platforms

Competition specific issues
• Ineligible applications:
• Product not CE marked
• Product still under development – not available for sale
• Total project costs outside limits
• % grant claimed
• Ineligible costs

• We must receive your application by noon on the closing date
• Your application will be sent and scored by 5 expert assessors – the assessors will
comment on your response to each question
• We will brief our assessors and the expert panel
• Assessors will be provided with a matrix against which to mark each question
• A quality line will be drawn and applicants above this line will be invited to present to
an interview panel
• All applicants will receive the assessor feedback, and those invited to interview will be
asked to address the feedback in a short written document ahead of the interview
General Competition Process

Applications:
• Make sure the application is in scope, we can give advice on scope but not how to fill
in the application form
• By far the most important issue – Answer the question, and the highlighted points,
the assessors will be marking against these points using clear guidance
• We have a quality threshold of 70%, if below this it is very unlikely a project will be
funded
Application Process

Question 1: Need or challenge
• What is the business need, citizen challenge, technological challenge or
market opportunity behind your innovation?
• Provide evidence of:
• the potential for your product to have a significant impact on patients or
the efficiency of care delivery by the NHS
• when the product was first marketed in the UK, as only products that
have been marketed for less than 5 years are eligible for support
•
Be guided by the application form

Good applications
• Try to be realistic about what amount of work can be completed in the
available time, and the costs
• Make sure you apply forthe correct total project costs and grantamount
• Get someone elseto review the application if possible, this can be the
KTN,particularly as space on the form can be quite limited

• Innovate UK funded projects are actively monitored
• Funding release quarterly in arrears
• All partners expected to attend quarterly meeting to report on progress
• Expectation that projects will start on time
• Progress and expenditure expected to follow forecasts
• Changes to scope and or financial including virements must be fully justified and are
subject to approval
Innovate UK – expectations

- Opens 2 July 2018
- Closes noon 22 August 2018
- Applicants informed 2 November 2018
• Full project brief and scope
- https://apply-for-innovation-funding.service.gov.uk/competition/190/overview
• Further support is available:
- via our competition helpline on 0300 321 4357
- or email support@innovateuk.gov.uk
• Additional competitions will follow
Competition dates and support

Overview of challenges and waves
3 July 2018
Dr Ian McKay ian.mckay@innovateuk.ukri.org
Innovate UK: Industrial Strategy

• Background to the Industrial Strategy and ISCF grand challenges
• Review of wave one
• Preview of wave two
• From data to early diagnosis and precision medicine
• Healthy ageing
• Update on wave three
• Other funding opportunities
Presentation overview

£31bn National Productivity Innovation Fund
Industrial Strategy Challenge Fund
£1.7bn over four years
Innovation, Applied Science & Research
£4.7bn R&D
Funding
(over four years
to FY20/21)

• Builds on the UK’s world-class research base and delivers the science that
business needs to transform existing industries and create new ones
• Accelerates commercial exploitation of the UK’s most exciting technologies to
ensure that scientific investment truly delivers economic impact, jobs and
growth right across the country
• Programmes supported by the fund must be for the benefit of UK companies
and the economy and powered by multi-disciplinary research and business-
academic collaboration
• From April 2018, delivered by UK Research and Innovation
Industrial Strategy Challenge Fund

ISCF Wave 1 Challenges
Medicines manufacturing technologies
Batteries for clean and flexible energy storage
Robots for a safer world
Self-driving vehicles
Manufacturing and materials of the future
Satellites and space technology

Digital Health Technology Catalyst
£35m to develop digital health or digitally-enabled medical technologies to:
• improve patient outcomes
• transform healthcare delivery
• enable more efficient delivery of healthcare
+
Medicines Manufacturing
£146m to develop first-of-a-kind technologies for the manufacture of tomorrow’s
medicines, accelerating patient access to new drugs and treatments:
• pharmaceuticals
• vaccines
• advanced therapies
Wave 1: Medicines Manufacturing

Industrial Strategy Grand Challenges
AI and Data
Economy
Ageing
Society
Clean
Growth
Future of
Mobility

109
Audience of the future / Next generation services (pioneer) / Quantum technology (pioneer)
Artificial intelligence and data economy
Clean growth
Energy revolution
Transforming
construction
Transforming
food production
Ageing Society
Medicines manufacturing
Data to early diagnosis and
precision medicine
Healthy ageing
Future of mobility
Faraday battery challenge
Extreme robotics
National space test facility
How the ISCF challenges fit with the
Industrial Strategy Grand Challenges

The report is organised into 7 themes:
• Health Advanced Research Programme
(HARP) proposal
• reinforcing the UK science offer
• growth and infrastructure
• NHS collaboration
• data
• skills
• regulation

• Three complementary strands:
• Genomics – ensure UK leads in exploitation of large scale whole genome
sequencing for diagnostics and precision medicine, £100m
• Digital Innovation Hubs – linking routine NHS data with rich data from
R&D programmes, providing analytic tools and informatics support for
businesses alongside local access to integrated UK-wide data, £38m
• Digital pathology, radiology/imaging and diagnosis– centres of
excellence in digital pathology and radiology/imaging with AI and
machine learning and investment in CR&D to advance diagnostic tools for
early diagnosis, £72m (£50m + £22m)
Data to early diagnosis and precision medicine

• Aims to position the UK at the forefront of large scale WGS for
diagnostics and precision medicine
• Whole Genome Sequencing of all 500,000 UK Biobank volunteers
• Potential for additional sequencing of up to 25,000 cancer patients (tumour
and germline genome) – funds permitting
• Overarching aim to support generation of
novel diagnostic tools and precision
therapies, in partnership with industry
ISCF: Genomics investment

• Delivered by UKRI in partnership with HDR UK and the NHS, building on
investments from NHS England and the devolved nations
• Hubs will provide expert research data services, supporting analytical tool
development and a range of innovative user requirements
• A single UK-wide health research data fabric will ensure interoperability
across all Hubs
• ~£38m over 4 years
ISCF: Digital Innovation Hubs

• Up to £50 million investment in a network of 5 – 6 Centres of Excellence
across the UK
• Split roughly £30m digital pathology, £20m radiology/in vivo imaging
• Applications can focus on digital pathology and/or radiology/in vivo imaging
• Maximum grant up to £10 million – this does not increase for multicentre bids
• Competition opens 6 June 2018, close 1 August 2018 at noon
• Projects to commence by 1 December 2018
• Maximum project length 36 months
• Programmes must be collaborative and at least 2 collaborators must apply
for grant.
Creating a network of digital pathology, imaging and AI
centres - a CR&D competition

Addressing the needs that improve quality
of life in the ISCF HA target audience
ISCF HA
Undesirable life
curve shows years
of dependency
years
Activitiesofdailyliving
(inorderoftypicallosspattern)
Public domain

Behaviora
l Studies
Innovatio
n
Clusters
Three elements Best current thinking….
Innovation Clusters
 Collaboration activity continues through the summer
 Opportunity for us to gain insight
 Out to competition later in the year
Behavioural Studies
 Dependant on the Innovation Cluster time line
 Out to competition later in the year
CR&D Academia and SMEs
 Out later in the year
 Bids in post New year
 Start around the new financial year
CR&D
Academi
a & SMEs
@innovateuk #healthyageingPublic domain

Innovation cluster
Lead Partner
Dynamic relationships
Short, rapid, innovation cycles
SME pipeline
Evaluation at local, programme
and national level
Economic and Social Impact
Build on existing collateral
Sustainable
SMEs
Local
Authorities
Third Sector/
NGOs
Clinical
Commissioning
Groups
Academia
Retail
companie
s
Logistics
companie
s
Large
Corporates
Marketing
Big Data
Health
Trusts
Care
Provider
s
HEIs/IROs
Design
Users &
carers
@innovateuk
#healthyageing
Community
Groups
Social
Enterprises
Utilities
Seed
Funders,
Venture
Capitalists
Public domain

• 252 Expressions of Interest received by the closing date
• c. £12.5bn requested from the Industrial Strategy Challenge Fund
• with c. £11.5bn additional funding coming from industry
Next steps and indicative timetable:
• Early July – Identify short-list of proposed challenges
• Summer – UKRI helps develop short-listed Expression of Interests
• Early September – deep-dive workshops with experts
• Mid October – UKRI reviews short listed challenges and makes
recommendations to ministers
• November (to be confirmed) – Announcement of selected challenges
Wave 3 Challenges

• Open programme funding competition round 1
• £20m opened 10 May closes 11 July, Round 2 closes 12 September
• Includes KTP applications
• Part of rolling programme of open competitions
• Precision medicine technologies: shaping the future
• £5m opened 14 May closes 11 July
• Creating a network of digital pathology, imaging and AI centres
• £50m funding available opened 6 June closes 1 August
Current funding competitions:

• Manufacturing readiness and scale up of genomic analysis technologies
• £5m opens 18 June, registration 11 July, closes 18 July
• Innovation loans: July 2018 open competition
• £10m competition opens 2 July, closes 29 August
• Precision Medicine Investment Accelerator 2018
• Opens 23 July closes 3 October
https://apply-for-innovation-funding.service.gov.uk/competition/search
Competition support 0300 321 4357 or support@innovateuk.gov.uk
https://www.ktn-uk.co.uk/
Current funding competitions:

Supporting UK innovative
businesses today in
developing the industries
of tomorrow

Innovative medical technologies

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Innovative medical technologies

Similar to Innovative medical technologies (20)

More from KTN

More from KTN (20)

Recently uploaded

Recently uploaded (20)

Innovative medical technologies